Brief: Centessa Pharmaceuticals Reports Fourth Quarter Net Loss Of $0.68 Per Share
March 30 (Reuters) - Centessa Pharmaceuticals PLC 260y.F :
* CENTESSA PHARMACEUTICALS REPORTS FOURTH QUARTER AND 2021
FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
* CENTESSA PHARMACEUTICALS PLC - COMPANY EXPECTS CASH AND
CASH
EQUIVALENTS WILL FUND OPERATIONS INTO EARLY 2024
* CENTESSA PHARMACEUTICALS PLC - QTRLY NET LOSS PER ORDINARY
SHARE
- BASIC AND DILUTED $0.68
Source text for Eikon: ID:nGNX8WdLNN
Further company coverage: 260y.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Centessa Pharmaceuticals
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Acquisition Of Centessa By Lilly Approved By The High Court Of Justice Of England And Wales
Street View: Lilly's $7.8 billion Centessa buyout validates sleep‑drug market
Press Digest: New York Times business news - April 1